PDF(1295 KB)
Screening of key differentially expressed genes involved in osteogenic differentiation of lower limb vascular smooth muscle cells and validation
Yingqun NI,Mao YANG,Di YANG,Chenglin GUO,Wenjun ZHU,Yaqin YU,Qin LU,Jinzhi LUO,Chunqin WU,Zhaohui FANG
PDF(1295 KB)
PDF(1295 KB)
Screening of key differentially expressed genes involved in osteogenic differentiation of lower limb vascular smooth muscle cells and validation
Objective To screen the differentially expressed genes (DEGs) under high phosphate-induced calcification in the vascular smooth muscle cells (VSMCs) by mRNA high-throughput sequencing technology, and to analyze the key genes and signaling pathways involved in the VSMCs calcification. Methods The human VSMCs were divided into control group and model group. The cells in model group was exposed to the high-phosphate medium, while the cells in control group were cultured in DMEM supplemented with 10% fetal bovine serum under the same conditions. The VSMCs in two groups, stably transfected, were cultured for 12 d. The morphology of the cells in two groups were observed and photographed under inverted microscope. The DEGs were selected by Hisat2 software, and Gene Ontology (GO) functional and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway enrichment analysis were performed by Stringtie software from three aspects, such as biological processes (BP), molecular functions (MF), and cellular components (CC). The calcification of the cells in two groups was observed by Von Kossa staining method. Real-time fluorescence quantitative PCR (RT-qPCR) method was used to analyze the expression levels of alkaline phosphatase (ALP), bone morphogenetic protein 2 (BMP2), alpha-smooth muscle actin (α-SMA), tumor protein 53 (Tp53), glutathione peroxidase 4 (GPX4), ferritin light chain 1 (Ftl1), and glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) mRNA in the cells in two groups. Results Compared with control group, there were 2 524 DEGs in the cells in model group, and there were 1 368 upregulated DEGs and 1 156 downregulated DEGs. Clustering of DEGs between the cells in two groups was distinct. The GO functional and KEGG pathway enrichment analysis results showed that the upregulated DEGs were primarily involved in regulating the microtubule cytoskeleton, cell polarity, protein localization, and cell cycle regulation among BPs; in constructing cell membrane, microtubule organization, chromosomes, and kinetochore among CCs; and functioning in phosphatidylinositol phosphate, Rho GTPase protein binding, transmembrane transport, and protein kinase regulatory activity among MFs. Downregulated DEGs were mainly involved in cytoplasmic translation, protein membrane localization, mRNA metabolism, and protein endoplasmic reticulum localization among BPs; in forming ribosome subunits, cell membrane, and autophagy among CCs; and functioning in single-stranded DNA, ribonucleoprotein complex, growth factor binding, regulating protein kinase activity, and catalytic activity among MFs. Seven signaling pathways were significantly enriched in upregulated genes, most notably in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors; whereas 18 signaling pathways were significantly enriched in the downregulated genes, most notably in ferroptosis.The RT-qPCR results showed that compared with control group, the expression levels of GPX4, Ftl1, and Tp53 mRNA in the cells in model group were significantly decreased (P<0.01), while the expression level of GPLD1 mRNA was significantly increased (P<0.01); compared with control group, the expression level of α-SMA mRNA in the cells in model group was significantly decreased (P<0.01), and the expression levels of ALP and BMP2 mRNA were significantly increased (P<0.01). Conclusion The VSMCs underwent calcification and normal cells exhibit the DEGs.The key signaling pathways in the calcification induced by high phosphate in the VSMCs include ferroptosis and GPI anchor biosynthesis, mediated primarily through GPX4, Ftl1, Tp53, and GPLD1.
Vascular smooth muscle cell / Osteogenic differentiation / Cell calcification / mRNA sequencing / Ferroptosis
Q254
| 1 | ALMAN A C, MAAHS D M, REWERS M J, et al. Ideal cardiovascular health and the prevalence and progression of coronary artery calcification in adults with and without type 1 diabetes[J]. Diabetes Care, 2014, 37(2): 521-528. |
| 2 | BERRY C, TARDIF J C, BOURASSA M G. Coronary heart disease in patients with diabetes: part Ⅰ: recent advances in prevention and noninvasive management[J]. J Am Coll Cardiol, 2007, 49(6): 631-642. |
| 3 | YAHAGI K, KOLODGIE F D, LUTTER C, et al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus[J]. Arterioscler Thromb Vasc Biol, 2017, 37(2): 191-204. |
| 4 | WANG P W, PANG Q, ZHOU T, et al. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease[J]. Atherosclerosis, 2022, 346: 36-45. |
| 5 | SáNCHEZ-DUFFHUES G, GARCíA DE VINUESA A, VAN DE POL V, et al. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2[J]. J Pathol, 2019, 247(3): 333-346. |
| 6 | LIU Q, LUO Y, ZHAO Y, et al. Nano-hydroxyapatite accelerates vascular calcification via lysosome impairment and autophagy dysfunction in smooth muscle cells[J]. Bioact Mater, 2021, 8: 478-493. |
| 7 | AHN B Y, JEONG Y, KIM S, et al. Cdon suppresses vascular smooth muscle calcification via repression of the Wnt/Runx2 Axis[J]. Exp Mol Med, 2023, 55(1): 120-131. |
| 8 | YE Y Z, CHEN A, LI L, et al. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification[J]. Kidney Int, 2022, 102(6): 1259-1275. |
| 9 | WANG Z Q, JIANG Y C, LIU N F, et al. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes[J]. Atherosclerosis, 2012, 221(2): 387-396. |
| 10 | 高 敏, 陈天雷, 吴 琳, 等. 吡格列酮通过 Wnt/β-catenin信号通路减轻大鼠血管平滑肌细胞钙化[J]. 肾脏病与透析肾移植杂志, 2016, 25(4): 340-346. |
| 11 | YAO H P, SUN Z, ZANG G Y, et al. Epidemiological research advances in vascular calcification in diabetes[J]. J Diabetes Res, 2021, 2021: 4461311. |
| 12 | VOELKL J, LANG F, ECKARDT K U, et al. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia[J]. Cell Mol Life Sci, 2019, 76(11): 2077-2091. |
| 13 | KONG Y L, LIANG Q C, CHEN Y T, et al. Hyaluronan negatively regulates vascular calcification involving BMP2 signaling[J]. Lab Invest, 2018, 98(10): 1320-1332. |
| 14 | MASUDA S, FUJISHIMA Y, MAEDA N, et al. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity[J]. Am J Physiol Endocrinol Metab, 2019, 316(2): E239-E250. |
| 15 | RAIKWAR N S, BOWEN-DEEG R F, DU X S, et al. Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance[J]. Metabolism, 2010, 59(10): 1413-1420. |
| 16 | TORRETTA S, RAMPINO A, BASSO M, et al. NURR1 and ERR1 modulate the expression of genes of a DRD2 coexpression network enriched for schizophrenia risk[J]. J Neurosci, 2020, 40(4): 932-941. |
| 17 | ABDOLMALEKI F, HEIDARIANPOUR A. Endurance exercise training restores diabetes-induced alteration in circulating Glycosylphosphatidylinositol-specific phospholipase D levels in rats[J]. Diabetol Metab Syndr, 2020, 12: 43. |
| 18 | QIN W, LIANG Y Z, QIN B Y, et al. The clinical significance of glycoprotein phospholipase D levels in distinguishing early stage latent autoimmune diabetes in adults and type 2 diabetes[J]. PLoS One, 2016, 11(6): e0156959. |
| 19 | SCHOFIELD J N, STEPHENS J W, HUREL S J, et al. Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats[J]. Mol Genet Metab, 2002, 75(2): 154-161. |
| 20 | WANG K, CHEN X Z, WANG Y H, et al. Emerging roles of ferroptosis in cardiovascular diseases[J]. Cell Death Discov, 2022, 8(1): 394. |
| 21 | ZHAO L L, YANG N, SONG Y Q, et al. Effect of iron overload on endothelial cell calcification and its mechanism[J]. Ann Transl Med, 2021, 9(22): 1658. |
/
| 〈 |
|
〉 |